Xarelto
Prevention of Atherothrombotic Events in Adult Patients After An Acute Coronary Syndrome with Elevated Cardiac Biomarkers, Co-administered with Acetylsalicylic Acid Alone or with Clopidogrel or Ticlopidine
15mg
Directly inhibits factor Xa to interrupt both intrinsic and extrinsic coagulation pathways, reducing thrombin generation and preventing formation and extension of blood clots.